Additional information Openhouse Method Div Active Ingredients from 01 10 2020Pharmaceutical productsShort Description Degree of non exclusive discount agreements according to 130a 8 SGB V with at any time with at any time in the context of so called Openhouse method for various drug active ingredients with the earliest possible contract start on 01 10 2020 The concrete pharmaceutical agents and the respective contract launches can be found in the current pharmaceutical device list in the project space of the DTVP procurement portal in the section Assignment documents On 01 10 2020 contracts for the following active ingredients are offered AbacavirAbacavir Dolutegravir LamivudinAbacavir Lamivudin ZidovudinAbataceptAcetylcystein rxAcetylcystein non rxAcetylsalicylic acid exclusively according to Appendix 1 AM RL G BA Regulatory ProductsAcitretinAdalimumabAgomelatinAlitetioninAmbrisentanAmphotericin BAnagrelide except N3 packs of the DAR HKP with 0 5 mg actual strengthApomorphinAprepitantAripiprazole except dar tablets melt tablets and solutions to takeAtazanavirAtomoxetineBenazepril HCTBimatoprostBiperidsBortezomibBosentenBrivudinCalcipotriolCalcium COLECALCIFEROLCapsaicin dar pavingChlorprothixesCinaacalcetCinnarizi DimenhydrinatClostridium botulinumClotrimazolColecalciferol Non RxCOLECALCIFEROL RXColistinCyproteronDABIGATRANDalteparinDenosumab Oncological IndicationDenosumab Orthopedic IndicationDesloratadinDesogrel EthinylestradiolDiengestDiengest EstradiolDiengest EthinylestradiolDISTIGMINDolutegravirDornase AlphaDrospirenone EthinylestradiolDutasteride TamsulosinEbastinEDOXBANEfavirenz Emtricitabine TenofovirIron II oral DAR excluding Appendix 1 AM RL G BA Regulatory ProductsEmtricitabineEmtricitabine Tenofovirdisoproxil RilpivirinEnoxaparin 20 mg and 40 mg active strengthEnoxaparin 60 mg 80 mg and 100 mg active strengthErlotinibErythropoietin EpoetinEstradiolEtanerceptEtravirinFebuxostatFentanyl except Dar matrix plaster pavement transdermal FilgrastimFlupentixol DecanoatFluvastatinFollitropin alfaFollitropin betaFondaparinux sodiumFosamprenavirFosfomycinFulfestrantFusidic acidFusidic acid betamethasoneGefitinibGlatirameracetate except 40 mg active strengthGoserelinHydrocortisoneHydromorphone Dar injection infusion solutionHydroxychloroquinHydroxyzineImmunoglobulins Normal Human Intravasal ApplicationInfliximabInterferon Beta 1a Avonex R IrbesartanIvabradinKetorolacLenograstimLeuprorelinLidocaine Dar pavingLIPEGFILGRASTIMLoperamideLopinavir RitonavirMacrogol exclusively according to Appendix 1 AM RL G BA Regulatory ProductsMacrogol exclusively to Appendix 5 AM RL G BA Regulatory Medical DevicesMeloxicamMeropenemMethocarbamol except dar film tablets with 750 mg active ingredient strengthMidazolamMigLustatNadroparinNaftidrofurylNatalizumabNifedipinNitrofurantoinOctreotideOxycodon NaloxonePaliperidonePalonosetron dar soft capsulesPancreatinParacetamol exclusively according to Appendix 1 AM RL G BA Regulatory ProductsPEGFILGRASTIMPeginterferon Alpha 2APeginterferon beta 1aPemetrexedPerindopril IndapamidPiroxicamPOSACONAZOLProgesterone except dar soft capsulesPromethazinePyridostigminRabeprazoleRaltegravirRitonavirRituximabRotigotinRupatadinSalmeterolSaquinavirSolifenacinSomatropinSorafenibSulfasalazinTacrolimus Amtl ATC L04AD02Tadalafil Ind Pulmonary hypertensionTapetadolTaurolidine exclusively to Appendix V AM RL G BA Regulatory Medical DevicesTeriparatideTiotropium Bromide Inh HKP M PLV Z INHTiotropium Bromid Inh LSGTobramycinTolvaptanTramadol ParacetamolTrastuzumabTravoprostTravoprost TimololTriporelinValsartan AmlodipinZidovudinThe contracts end uniformly on 30 09 2022 Deadline for Submission 20220815 12 00Type of Buyer Body governed by public lawType of Contract SuppliesType of Procedure Open procedureRegulation European Union with participation by GPA countriesType of Bid Submission for all lotsAward Criteria The most economic tender Disclaimer The above text is machine translated For accurate information kindly refer the original document
We takes all possible care for accurate & authentic tender information, however Users are requested to refer Original source of Tender Notice / Tender Document published by Tender Issuing Agency before taking any call regarding this tender.
